World Wires · story 5318 · unverified · 1 source(s)

Medicus Pharma Submits Teverelix Protocol to FDA

Medicus Pharma submitted an optimized registrational protocol for Teverelix to the FDA to create a partner-ready program in advanced prostate cancer.

Open in the desk

Coverage

• Medicus Pharma Submits Teverelix Protocol to FDA GlobeNewswire: public companies · tier D · clear net · 2026-09-29 11:30 UTC

What this site indexes